<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02137265</url>
  </required_header>
  <id_info>
    <org_study_id>2014-0343</org_study_id>
    <nct_id>NCT02137265</nct_id>
  </id_info>
  <brief_title>Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism</brief_title>
  <official_title>A Randomized, Double-blind, Placebo-controlled Trial of Clomiphene Citrate of Clomiphene Citrate in Hypoandrogenism and Azoospermia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Illinois at Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Illinois at Chicago</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: Prescribed clomiphene citrate to azoospermic patients with hypoandrogenism could
      improve the sperm retrieval in either fresh sperm or after surgical sperm extraction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Hypogonadism (low testosterone level) is frequently observed in men presenting with non
      obstructive azoospermia. Controversy exists regarding the efficacy of preoperative hormonal
      manipulation in patients with hypogonadism. However, it is possible that hormonal therapy
      increases intra-testicular testosterone levels, and with a rise in serum testosterone, sperm
      production and surgical success with microTESE improve.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of sperm in the ejaculated or in the microsurgical testicular Sperm extraction (microTESE)</measure>
    <time_frame>After four months of clomiphene treatment</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Epigenetic modifications</measure>
    <time_frame>After four months of clomiphene treatment</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Testosterone levels and Bioavailable Testosterone levels</measure>
    <time_frame>After two weeks and four months with clomiphene treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">158</enrollment>
  <condition>Non Obstructive Azoospermia</condition>
  <condition>Hypogonadism</condition>
  <arm_group>
    <arm_group_label>Clomiphene citrate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clomiphene citrate 50 mg daily during 4-6 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (1 pill daily) during 4-6 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clomiphene</intervention_name>
    <description>Clomiphene citrate 50 mg orally daily</description>
    <arm_group_label>Clomiphene citrate</arm_group_label>
    <other_name>Clomid</other_name>
    <other_name>Serophene</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>One pill every other day</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients over 18 years old.

          -  Man seeking fertility treatment.

          -  Azoospermia confirmed in at least 2 semen analyses with centrifugation.

          -  Testosterone &lt;300 ng/dL and Bioavailable Testosterone&lt;156 ng/dL.

        Exclusion Criteria:

          -  Presence of genetic disorders: Y chromosome deletions or abnormal karyotypes.

          -  Luteinizing hormone (LH) &gt;25 IU/mL.

          -  Estradiol &gt; 40 ng/dL.

          -  Hypogonadotropic hypogonadism (LH &lt;2 IU/mL and Follicle Stimulating Hormone (FSH) &lt;1
             IU/mL).

          -  Obstructive azoospermia (FSH &lt;7.6 IU/mL plus testicle longitudinally axis &gt;4.6 cm or
             bilateral absence of vas deferens or surgical history of vasectomy).

          -  Clinical varicocele (palpable or visible in physical exam)

          -  Previous history of cryptorchidism.

          -  Use of chemotherapy, testosterone, or anti-androgen in the last two years. Partner &gt;40
             years or female factor infertility associated.

          -  Contraindications to clomiphene use: depression, heart and liver impairment,
             uncontrolled thyroid/adrenal dysfunction, organic intracranial lesions.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saturnino Luj치n, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Valencia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Saturnino Luj치n, MD, PhD</last_name>
    <phone>3129969330</phone>
    <email>satlujan@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Craig Niederberger, MD, FRCS</last_name>
    <phone>3129969330</phone>
    <email>craignied@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Valencia</name>
      <address>
        <city>Valencia</city>
        <state>Province of Valencia</state>
        <zip>46010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Satur Luj치n, MD, PhD</last_name>
      <phone>+34 616 936 453</phone>
      <phone_ext>440692</phone_ext>
      <email>satlujan@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Craig S Niederberger, MD, FACS</last_name>
      <phone>3129969330</phone>
      <email>craign@uic.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Satur Luj치n, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <results_reference>
    <citation>Hussein A, Ozgok Y, Ross L, Niederberger C. Clomiphene administration for cases of nonobstructive azoospermia: a multicenter study. J Androl. 2005 Nov-Dec;26(6):787-91; discussion 792-3.</citation>
    <PMID>16291975</PMID>
  </results_reference>
  <results_reference>
    <citation>Hussein A, Ozgok Y, Ross L, Rao P, Niederberger C. Optimization of spermatogenesis-regulating hormones in patients with non-obstructive azoospermia and its impact on sperm retrieval: a multicentre study. BJU Int. 2013 Mar;111(3 Pt B):E110-4. doi: 10.1111/j.1464-410X.2012.11485.x. Epub 2012 Sep 7.</citation>
    <PMID>22958644</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2014</study_first_submitted>
  <study_first_submitted_qc>May 12, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 13, 2014</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Illinois at Chicago</investigator_affiliation>
    <investigator_full_name>Dr. Craig Niederberger</investigator_full_name>
    <investigator_title>Clarence C. Saelhof Professor and Head, Department of Urology, UIC College of Medicine</investigator_title>
  </responsible_party>
  <keyword>Azoospermia</keyword>
  <keyword>Hypogonadism</keyword>
  <keyword>Clomiphene</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypogonadism</mesh_term>
    <mesh_term>Azoospermia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Clomiphene</mesh_term>
    <mesh_term>Enclomiphene</mesh_term>
    <mesh_term>Zuclomiphene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

